title: Zoster vaccine recommendations: the importance of using a clinically valid correlate of protection.
authors.forename: Michael N
authors.initials: MN
authors.lastname: Oxman
authors.forename: Anne A
authors.initials: AA
authors.lastname: Gershon
authors.forename: Gregory A
authors.initials: GA
authors.lastname: Poland
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000914:Antibodies, Viral / Q000097:blood; D000917:Antibody Formation; D006562:Herpes Zoster / Q000517:prevention & control*; D053061:Herpes Zoster Vaccine / Q000008:administration & dosage* / Q000276:immunology; D006801:Humans; D022242:Pneumococcal Vaccines / Q000008:administration & dosage*; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D014611:Vaccination
chemical_list: D000914:Antibodies, Viral; D053061:Herpes Zoster Vaccine; D022242:Pneumococcal Vaccines